$RLYB 8-K SEC Filings

Filed On	Filing
26 Oct 2026	8-K: Other Events As previously disclosed, on May 31, 2026, the Rallybio Corporation, a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Avenzo Therapeutics, Inc., a Delawa...
09 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation This letter agreement (this “Agreement”) is made and entered into as of this 8th day of September, 2026 (the “Effective Date”) by and among Rallybio Corporation (“Rallybio”), a Delaware corporation, Rallybio, LLC (“Rallybio LLC”), a Dela...
01 Jun 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +3 more
04 May 2026	8-K: Termination of a Material Definitive Agreement
31 Mar 2026	8-K: Departure/Election of Directors or Officers; Compensation
02 Mar 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +3 more
29 Jan 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
06 Nov 2025	8-K: Results of Operations and Financial Condition
29 Aug 2025	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
07 Aug 2025	8-K: Results of Operations and Financial Condition
08 Jul 2025	8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +1 more
27 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation
16 May 2025	8-K: Submission of Matters to a Vote of Security Holders
08 May 2025	8-K: Results of Operations and Financial Condition
08 Apr 2025	8-K: Other Events
13 Mar 2025	8-K: Other Events
13 Mar 2025	8-K: Results of Operations and Financial Condition
25 Feb 2025	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
07 Nov 2024	8-K: Results of Operations and Financial Condition
17 Sep 2024	8-K: Departure/Election of Directors or Officers; Compensation

Comments